These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24129238)

  • 1. Validation of the Children's International Mucositis Evaluation Scale (ChIMES) in paediatric cancer and SCT.
    Jacobs S; Baggott C; Agarwal R; Hesser T; Schechter T; Judd P; Tomlinson D; Beyene J; Sung L
    Br J Cancer; 2013 Nov; 109(10):2515-22. PubMed ID: 24129238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of healthcare professional proxy-reported children's International Mucositis Evaluation Scale.
    Treister NS; Nieder M; Baggott C; Olson E; Lo T; Jin X; Gao Y; Chen L; Dang H; Sung L
    Oral Dis; 2023 Mar; 29(2):747-754. PubMed ID: 33993618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Children's International Mucositis Evaluation Scale Is Valid and Reliable for the Assessment of Mucositis Among Brazilian Children With Cancer.
    Paiva BSR; Barroso EM; Cadamuro SA; Paula LAB; Pirola WE; Serrano CVMP; Paiva CE
    J Pain Symptom Manage; 2018 Nov; 56(5):774-780.e2. PubMed ID: 30053485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Refinement of the Children's International Mucositis Evaluation Scale (ChIMES): child and parent perspectives on understandability, content validity and acceptability.
    Tomlinson D; Gibson F; Treister N; Baggott C; Judd P; Hendershot E; Maloney AM; Doyle J; Feldman B; Kwong K; Sung L
    Eur J Oncol Nurs; 2010 Feb; 14(1):29-41. PubMed ID: 19955021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understandability, content validity, and overall acceptability of the Children's International Mucositis Evaluation Scale (ChIMES): child and parent reporting.
    Tomlinson D; Gibson F; Treister N; Baggott C; Judd P; Hendershot E; Maloney AM; Doyle J; Feldman B; Kwong K; Sung L
    J Pediatr Hematol Oncol; 2009 Jun; 31(6):416-23. PubMed ID: 19648790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychometric properties of the Oral Mucositis Daily Questionnaire for child self-report and importance of mucositis in children treated with chemotherapy.
    Manji A; Tomlinson D; Ethier MC; Gassas A; Maloney AM; Sung L
    Support Care Cancer; 2012 Jun; 20(6):1251-8. PubMed ID: 21681385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and initial evaluation of electronic Children's International Mucositis Evaluation Scale (eChIMES) for children with cancer.
    Tomlinson D; Hesser T; Maloney AM; Ross S; Naqvi A; Sung L
    Support Care Cancer; 2014 Jan; 22(1):115-9. PubMed ID: 24000043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Phase IIb, Multicenter, Open-Label, Safety, and Efficacy Study of High-Dose, Propylene Glycol-Free Melphalan Hydrochloride for Injection (EVOMELA) for Myeloablative Conditioning in Multiple Myeloma Patients Undergoing Autologous Transplantation.
    Hari P; Aljitawi OS; Arce-Lara C; Nath R; Callander N; Bhat G; Allen LF; Stockerl-Goldstein K
    Biol Blood Marrow Transplant; 2015 Dec; 21(12):2100-2105. PubMed ID: 26327631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Incidence and Severity of Oral Mucositis among Allogeneic Hematopoietic Stem Cell Transplantation Patients: A Systematic Review.
    Chaudhry HM; Bruce AJ; Wolf RC; Litzow MR; Hogan WJ; Patnaik MS; Kremers WK; Phillips GL; Hashmi SK
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):605-616. PubMed ID: 26409924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective oral mucositis audit: oral mucositis in patients receiving high-dose melphalan or BEAM conditioning chemotherapy--European Blood and Marrow Transplantation Mucositis Advisory Group.
    Blijlevens N; Schwenkglenks M; Bacon P; D'Addio A; Einsele H; Maertens J; Niederwieser D; Rabitsch W; Roosaar A; Ruutu T; Schouten H; Stone R; Vokurka S; Quinn B; McCann S;
    J Clin Oncol; 2008 Mar; 26(9):1519-25. PubMed ID: 18268357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The 20 item oral mucositis index: reliability and validity in bone marrow and stem cell transplant patients.
    McGuire DB; Peterson DE; Muller S; Owen DC; Slemmons MF; Schubert MM
    Cancer Invest; 2002; 20(7-8):893-903. PubMed ID: 12449720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low incidence and severity of oral mucositis in allogeneic stem cell transplantation after conditioning with treosulfan and fludarabine.
    Heli U; Eeva J; Anne N; Tapani R; Liisa V
    Eur J Haematol; 2012 Jan; 88(1):87-8. PubMed ID: 22103782
    [No Abstract]   [Full Text] [Related]  

  • 13. Parents and children's perceptions of distress related to oral mucositis during haematopoietic stem cell transplantation.
    Kamsvåg-Magnusson T; Thorsell-Cederberg J; Svanberg A; von Essen L; Arvidson J; Mellgren K; Toporski J; Ljungman G
    Acta Paediatr; 2014 Jun; 103(6):630-6. PubMed ID: 24612395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing the incidence and severity of oral mucositis in patients undergoing autologous stem cell transplantation.
    Salvador PT
    Can Oncol Nurs J; 2005; 15(1):29-34. PubMed ID: 15779780
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caphosol for prevention of oral mucositis in pediatric myeloablative haematopoietic cell transplantation.
    Treister N; Nieder M; Baggott C; Olson E; Chen L; Dang H; Krailo M; August A; Sung L
    Br J Cancer; 2017 Jan; 116(1):21-27. PubMed ID: 27875526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Prospective Oral Mucositis Audit: relationship of severe oral mucositis with clinical and medical resource use outcomes in patients receiving high-dose melphalan or BEAM-conditioning chemotherapy and autologous SCT.
    McCann S; Schwenkglenks M; Bacon P; Einsele H; D'Addio A; Maertens J; Niederwieser D; Rabitsch W; Roosaar A; Ruutu T; Schouten H; Stone R; Vorkurka S; Quinn B; Blijlevens N;
    Bone Marrow Transplant; 2009 Jan; 43(2):141-7. PubMed ID: 18776926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective longitudinal analysis of clinical and immunological risk factors associated with oral and gastrointestinal mucositis following autologous stem cell transplant in adults.
    Wong SP; Tan SM; Lee CS; Law KB; Lim YAL; Rajasuriar R
    Support Care Cancer; 2023 Jul; 31(8):494. PubMed ID: 37498423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral cryotherapy for oral mucositis management in patients receiving allogeneic hematopoietic stem cell transplantation: a prospective randomized study.
    Lu Y; Zhu X; Ma Q; Wang J; Jiang P; Teng S; Zhou L; Wu D; Wang H
    Support Care Cancer; 2020 Apr; 28(4):1747-1754. PubMed ID: 31302767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Mucositis after allogeneic stem cell transplantation: Risk factors, clinical consequences and prophylaxis].
    Bourdelin M; Daguindau E; Larosa F; Legrand F; Nerich V; Deconinck E; Limat S
    Pathol Biol (Paris); 2015 Apr; 63(2):106-10. PubMed ID: 25555496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Severe gastrointestinal mucositis following high dose melphalan therapy for multiple myeloma.
    Sharma SK; Handoo A; Choudhary D; Dhamija G; Gupta N
    World J Gastroenterol; 2013 Feb; 19(5):784-5. PubMed ID: 23429569
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.